Type 1 regulatory T cell-mediated tolerance in health and disease

被引:21
|
作者
Freeborn, Robert A. [1 ]
Strubbe, Steven [1 ]
Roncarolo, Maria Grazia [1 ,2 ,3 ]
机构
[1] Stanford Sch Med, Dept Pediat, Div Hematol Oncol Stem Cell Transplantat & Regener, Stanford, CA 94305 USA
[2] Stanford Sch Med, Inst Stem Cell Biol & Regenerat Med ISCBRM, Stanford, CA 94305 USA
[3] Stanford Sch Med, Ctr Definit & Curat Med CDCM, Stanford, CA 94305 USA
来源
FRONTIERS IN IMMUNOLOGY | 2022年 / 13卷
基金
中国国家自然科学基金;
关键词
Type 1 regulatory T (Tr1) cells; immunological tolerance; autoimmunity; inflammatory bowel disease; infectious disease; RECURRENT HEPATITIS-C; DENDRITIC CELLS; HELPER TYPE-1; IFN-GAMMA; INTERLEUKIN-10; PRODUCTION; IMMUNE-RESPONSES; IL-10; TR1; CELLS; IN-VIVO; DIFFERENTIATION;
D O I
10.3389/fimmu.2022.1032575
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Type 1 regulatory T (Tr1) cells, in addition to other regulatory cells, contribute to immunological tolerance to prevent autoimmunity and excessive inflammation. Tr1 cells arise in the periphery upon antigen stimulation in the presence of tolerogenic antigen presenting cells and secrete large amounts of the immunosuppressive cytokine IL-10. The protective role of Tr1 cells in autoimmune diseases and inflammatory bowel disease has been well established, and this led to the exploration of this population as a potential cell therapy. On the other hand, the role of Tr1 cells in infectious disease is not well characterized, thus raising concern that these tolerogenic cells may cause general immune suppression which would prevent pathogen clearance. In this review, we summarize current literature surrounding Tr1-mediated tolerance and its role in health and disease settings including autoimmunity, inflammatory bowel disease, and infectious diseases.
引用
收藏
页数:18
相关论文
共 50 条
  • [1] Type 1 regulatory T cell-mediated tolerance in health and disease (vol 13, 1032575, 2022)
    Freeborn, R. A.
    Strubbe, S.
    Roncarolo, M. G.
    FRONTIERS IN IMMUNOLOGY, 2023, 13
  • [2] Regulatory T cell-mediated transplantation tolerance
    Bharat, Ankit
    Fields, Ryan Courtney
    Mohanakumar, T.
    IMMUNOLOGIC RESEARCH, 2005, 33 (03) : 195 - 212
  • [3] Regulatory T cell-mediated transplantation tolerance
    Ankit Bharat
    Ryan Courtney Fields
    T. Mohanakumar
    Immunologic Research, 2005, 33 : 195 - 212
  • [4] Regulatory T cell-mediated tolerance to myelin basic protein
    Cabbage, S. E.
    Goverman, J.
    CURRENT TOPICS IN NEUROIMMUNOLOGY, 2006, : 71 - 75
  • [5] NAC1 modulates autoimmunity by suppressing regulatory T cell-mediated tolerance
    Yang, Jin-Ming
    Ren, Yijie
    Kumar, Anil
    Xiong, Xiaofang
    Das, Jugal Kishore
    Peng, Hao-Yun
    Wang, Liqing
    Ren, Xingcong
    Zhang, Yi
    Ji, Cheng
    Cheng, Yan
    Zhang, Li
    Alaniz, Robert C.
    de Figueiredo, Paul
    Fang, Deyu
    Zhou, Hongwei
    Liu, Xiaoqi
    Wang, Jianlong
    Song, Jianxun
    SCIENCE ADVANCES, 2022, 8 (26)
  • [6] Integrin Activation Controls Regulatory T Cell-Mediated Peripheral Tolerance
    Klann, Jane E.
    Kim, Stephanie H.
    Remedios, Kelly A.
    He, Zhaoren
    Metz, Patrick J.
    Lopez, Justine
    Tysl, Tiffani
    Olvera, Jocelyn G.
    Ablack, Jailal N.
    Cantor, Joseph M.
    Boland, Brigid S.
    Yeo, Gene
    Zheng, Ye
    Lu, Li-Fan
    Bui, Jack D.
    Ginsberg, Mark H.
    Petrich, Brian G.
    Chang, John T.
    JOURNAL OF IMMUNOLOGY, 2018, 200 (12): : 4012 - 4023
  • [7] Immune regulatory effects of simvastatin on regulatory T cell-mediated tumour immune tolerance
    Lee, K. J.
    Moon, J. Y.
    Choi, H. K.
    Kim, H. O.
    Hur, G. Y.
    Jung, K. H.
    Lee, S. Y.
    Kim, J. H.
    Shin, C.
    Shim, J. J.
    In, K. H.
    Yoo, S. H.
    Kang, K. H.
    Lee, S. Y.
    CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2010, 161 (02): : 298 - 305
  • [8] Type 1 narcolepsy: a CD8+ T cell-mediated disease?
    Degn, Matilda
    Kornum, Birgitte Rahbek
    NEUROIMMUNOMODULATION IN HEALTH AND DISEASE, 2015, 1351 : 80 - 88
  • [9] Regulatory T Cell-Mediated Tissue Repair
    Hong, Jihye
    Kim, Byung-Soo
    BIOMIMETIC MEDICAL MATERIALS: FROM NANOTECHNOLOGY TO 3D BIOPRINTING, 2018, 1064 : 221 - 233
  • [10] Role of regulatory T cell-mediated suppression
    Ullrich, N.
    Bopp, T.
    Stahl, H.
    Fauti, T.
    Mennerich, D.
    Schmitt, E.
    Schild, H.
    WIENER KLINISCHE WOCHENSCHRIFT, 2008, 120 : 172 - 172